- £701.05m
- £678.05m
- £145.26m
Annual cashflow statement for Ergomed, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | 4.99 | 12.6 | 14.3 | 15 |
| Depreciation | |||||
| Non-Cash Items | 7.72 | 3.34 | 0.476 | 2.73 | 2.81 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.61 | -0.252 | 0.101 | -3.36 | -8.78 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.1 | 11.8 | 18 | 18.7 | 14.8 |
| Capital Expenditures | -1.59 | -0.996 | -0.974 | -0.983 | -1.92 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.2 | -1.83 | -11.8 | -3.16 | -24.2 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.79 | -2.83 | -12.8 | -4.15 | -26.1 |
| Financing Cash Flow Items | -0.187 | 0 | -0.157 | -0.169 | -0.761 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.77 | -0.25 | -0.477 | -2.11 | -2.37 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.97 | 9.07 | 4.74 | 12.2 | -12.1 |